Fetal stem cell transplantation may rely on material from therapeutic
abortions. It is essential that the stem cell transplant does not tran
smit any microorganism that may affect the fetus and that genetically
abnormal cells are avoided. To evaluate such contamination, human feta
l stem cells collected February 1992 - December 1993 were analyzed for
bacterial and fungal growth, and the placentas were karyotyped. Four
samples of 70 were positive for different pathogens. Serological scree
ning of 43 women during this period resulted in five seroconversions a
nd revealed one carrier of anti-HCV. Karyotyping revealed two abnormal
findings out of 72 samples. Thus, the concept of using material from
therapeutic abortions is safe.